• Latest Posts

This French Startup brings Gene Therapy to Neurodegenerative Diseases

Novel biopharma’s therapy for Traumatic Brain Injury heads to Phase III

New non-amphetaminic ADHD drug ‘speeds’ into Phase II

US Money Magnet get hands on UK Bispecific Antibodies for Neurodegenerative Disease

The Brain’s Sleep Switch was just discovered, zZz …

Google and GSK invest €630M to create a new Bioelectronics Champion

ADVERTISEMENT

World first Drug to ‘dissolve’ Tau-tangles in Alzheimer’s has Phase III Results

Oryzon develops Epigenetic Therapies against Cancer and Alzheimer’s

Sci-fi Spinal Cord Implant could help Paralyzed Patients walk again

French Biotech that makes Drugs faster and cheaper IPO’s for €31M

Newly Approved therapy reduces frequency of Multiple Sclerosis relapses by 54%

Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s

ADVERTISEMENT